• Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research
• Bausch + Lomb will also sponsor The Glaucoma Foundation’s annual month-long educational social media campaign, which spotlights stories from glaucoma patients and advocates
• Glaucoma affects about four million people in the United States¹

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation’s (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.

“Currently, about four million people in the United States are affected by glaucoma, and this number is only expected to grow as the population ages,” said Andrew Stewart, president, Global Pharmaceuticals and International Consumer, Bausch + Lomb. “Our collaborations with GRF and TGF will advance education and research efforts designed to improve the lives of those affected by glaucoma and encourage everyone to be proactive when it comes to eye health.”

As part of the fundraising challenge with GRF, Bausch + Lomb will match every dollar raised during January, up to $20,000. All proceeds will support critical research for glaucoma, a leading cause of irreversible blindness in the U.S.¹

“Glaucoma often progresses without noticeable symptoms, making research and improved education vital to saving sight,” said Thomas M. Brunner, president and CEO, Glaucoma Research Foundation. “Our continued partnership with Bausch + Lomb supports our efforts to accelerate the discoveries that can make a real difference for people living with this disease.”

Learn more about GRF or make a donation at www.glaucoma.org.

TGF’s social media campaign aims to put a human face to the disease, raise awareness and stress the importance of early detection by sharing personal stories from a patient or advocate each day during the month of January.

“Due to the chronic, progressive nature of glaucoma, early intervention can mean the difference between saving and losing sight,” said Elena Sturman, president and CEO, The Glaucoma Foundation. “In partnership with Bausch + Lomb, our campaign will showcase real-world experiences with glaucoma, create greater awareness and bring hope to those affected by this disease.”

Learn more about The Glaucoma Foundation at www.glaucomafoundation.org and follow the organization on Facebook, Instagram, LinkedIn and X to experience the social media campaign throughout Glaucoma Awareness Month.

About Glaucoma

Glaucoma is a chronic, progressive disease that occurs when excessive eye pressure or other causes lead to damage of the optic nerve. The optic nerve is responsible for the communication of information between the eye and brain. Damage to the optic nerve can lead to severe vision loss, and in the worst case, blindness. As the leading cause of irreversible blindness, glaucoma affects about four million people in the United States, but if caught early, it is possible to help slow and potentially prevent vision loss.^1-3

About Bausch + Lomb

Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

About Glaucoma Research Foundation

Glaucoma Research Foundation (GRF) is a national non-profit organization dedicated to finding a cure for glaucoma. GRF funds glaucoma research worldwide and serves as the leading information source for patients and their families. Founded in 1978 in San Francisco, GRF was created to encourage innovative research to find better ways to care for people with glaucoma — the leading cause of preventable blindness. Since its inception, GRF has invested more than $90 million to fund breakthrough research to better understand, detect, and treat glaucoma.

About The Glaucoma Foundation

Since 1984, The Glaucoma Foundation has worked to identify, encourage, and fund scientific research into the potentially blinding disease of glaucoma, with the goal of eradicating vision loss and blindness from glaucoma. Through education and outreach, we strive to be a valuable resource to improve the lives of those affected by the disease.

References

1. Ehrlich JR, Burke-Conte Z, Wittenborn JS, et al. Prevalence of Glaucoma Among US Adults in 2022. JAMA Ophthalmol. 2024;142(11):1046–1053. doi:10.1001/jamaophthalmol.2024.3884
2. John Hopkins. Glaucoma. Retrieved from https://www.hopkinsmedicine.org/health/conditions-and-diseases/glaucoma. Reviewed on Nov. 7, 2025.
3. National Eye Institute. Glaucoma and Eye Pressure. Retrieved from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma/glaucoma-and-eye-pressure. Reviewed on Nov. 7, 2025.

© 2025 Bausch + Lomb.

BLNP.0137.USA.25

View source version on businesswire.com: https://www.businesswire.com/news/home/20260105643250/en/